Oculis: Clinical Trials

6 trials sponsored by Oculis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 22Active not recruiting 1, Completed 1

Follow Oculis: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Privosegtor, Methylprednisolone, Placebo - Optic Neuritis
Phase 3RecruitingOculis2102026-05-282026-08-14
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Artificial Tear Run-in, licaminlimab, Vehicle of licaminlimab - Dry Eye Disease (DED)
Phase 2 / Phase 3Active not recruitingOculis1602026-04-162026-10-27
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
Dexamethasone ophthalmic suspension (OCS-01), Vehicle - Diabetic Macular Edema
Phase 3CompletedOculis4012024-03-152026-05-01
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
OCS-01, Vehicle - Inflammation Eye Pain, Postoperative Cataract
Phase 3TerminatedOculis1172023-12-182026-07-30
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
OCS-01, Vehicle - Inflammation Eye Pain, Postoperative Cataract
Phase 3CompletedOculis2412022-06-242025-07-11
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
Dexamethasone ophthalmic suspension (OCS-01), Vehicle - Diabetic Macular Edema
Phase 2 / Phase 3CompletedOculis5522021-10-192026-05-05

Conditions studied

Dry Eye Syndromes (1)  ·  Multiple Sclerosis (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)  ·  Vision Disorders (1)

Interventions

Dexamethasone (2)  ·  Methylprednisolone (1)

Countries

United States (6)  ·  India (2)  ·  Argentina (1)  ·  Hong Kong (1)  ·  Puerto Rico (1)  ·  Taiwan (1)

Top investigators

Diana Do, MD (1)  ·  Veeral S Sheth, MD (1)

Results publications

PMID 42564608